MQX-3016

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMQX-3016
Drug Alias Nameactinic keratosis therapy (MediQuest)Antizyme inducer (MediQuest Therapeutics)MQX-3016
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsKeratosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMediquest Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMediquest Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsKeratosis

Other Information

ATC CodeN/A
Related LinksN/A